UNSPSC 51422510: Oxisopred

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H28O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0C39YBM73T, chemically known as 11beta,17,21-trihydroxy-b-homo-a-norpregn-1-ene-3,6,20-trione but generally known as oxisopred, which bears US NIH Compound Identifier 3047809. European Medicines Agency schedules Oxisopred in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09538MIG.

UNSPSC 51422510 Oxisopred is a Commodity code that covers pharmaceutical products used in emergency medical and public health response, specifically opioid antagonists and related drug management systems procured by state and local health departments and county health authorities. State and local governments use this code to acquire naloxone and associated drug deactivation systems for community health initiatives, overdose response programs, and emergency medical stockpiles. The solicitations under this code reflect a narrow but critical procurement stream: counties and municipal health agencies source naloxone in bulk quantities alongside complementary harm-reduction and drug-disposal equipment, typically through competitive bidding processes that bundle pharmaceutical acquisition with delivery logistics and ongoing inventory management.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The procurement required electronic submission through the county's e-Procurement Portal, included delivery costs in vendor pricing, mandated E-Verify compliance and drug-free workplace certification, and carried a two-year initial term with an option for one-year renewal. The contract was potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Geographic activity under this code is limited; the recent-opportunities block supports Florida as an active jurisdiction, with no visibility into broader state or regional concentration. Repeat buyers or standout issuing bodies do not appear in the current dataset.